Why inhaled?
- Act quickly and precisely (cf systemic), lower-dose required
- Neutralize infection quickly, fewer (and less severe) unwanted effects
- Sustained action and minimal emergence of resistance
- Lower costs and better compliance
Pulmocide is generating a pipeline of novel, potent first-in-class anti-infective agents for delivery by inhaled administration for the treatment of life-threatening lower respiratory tract viral and fungal infections.